Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Upcoming Catalysts Matter For Owlet Owlt Stock Price At 5.10 Up 1.80 20260328 What Limits Growth Of Agora Api Stock Api Market Analysis 20260408 1 Is Regeneron Pharmaceuticals Regn Stock Expanding Regn Q4 Earnings Beats Estimates By 0.61 20260406 1 What Support Levels Matter For Centerspace Csr Stock Price At 60.88 Up 1.16 20260408 NTRB Nutriband Inc Q1 2026 results far outperform loss estimates post mild revenue gains as shares rise modestly The key risks discussed in Zevia PBC ZVIA earnings Q1 2026 EPS Tops Views What separates Hyperscale Data GPUS from the pack 769 20260507 Wintrust WTFC Economic Sensitivity Q4 2025 Profit Exceeds Views The organic vs inorganic growth story at CreditAccept CACC Q1 2026 Below Expectations What Seritage SRG disclosed about legal liabilities SRG Q3 Earnings Seritage Reports NA Results as Retail Property Challenges Persist TY Tri quarterly earnings core performance metrics are still undisclosed as investors await management near term operational guidance updates Is Western WU stock attractive for shortterm traders Calm 20260420 SPIR Spire Global posts wider than expected Q4 2025 loss as shares tick higher on favorable investor sentiment ASPCR A SPAC III publishes latest quarterly earnings remains focused on identifying viable deSPAC merger targets RGEN Repligen Corporation shares rise 46 percent after Q4 2025 EPS beats consensus estimates by 93 percent What makes Lion Group LGHL a safer bet than newer entrants Bearish Sentiment 20260506 Pony AI Inc PONY in the Autonomous Driving Race A Closer Look at the Young Tech Contender Goldman Sachs CEO David Solomons Early Career From BaskinRobbins to McDonalds A Lesson in Time Management Enanta Pharmaceuticals ENTA Delivers Q1 2026 Beat EPS 045 vs 050 Expected Vera Bradley VRA Q1 2026 Earnings Beat Revenue NA EPS 009 Organigram OGI Flat at 111 Consolidation Continues 20260514 ConnectOne CNOBP Stalls at 2479 Consolidation Phase 20260518 MasTec MTZ Climbs 088 Resistance at 44889 in Focus 20260514 Kyivstar KYIV Gained 135 Can It Break 1414 20260518 Birchtech BCHT Q1 2026 Earnings Miss Sparks Concern K2 Capital Rights KTWOR Holds Steady at 019 Amid RangeBound Trading Remitly Global RELY Down 148 How Low Could It Go 20260521 Google Plans Autumn Launch of AIPowered Smart Glasses Reviving Wearable Ambitions Intuit Earnings Results Challenge Morgan Stanleys Stock Forecast as Market Awaits Implications INGs AIPowered Trading System Built in Hours Draws Wall Street Attention Amazon Appoints Amwell CoFounder Dr Roy Schoenberg as New Health Chief Should You Let a Prospective Employer Contact Your Current Boss Key Considerations for Job Seekers Microsoft Appoints New Responsible Tech Lead to Guide Ethical AI Development Novartis Upgrades FullYear Outlook Raises Sales and Profit Guidance Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong ALZN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Management Amid PreRevenue Phase IEP Q1 2026 Earnings Severe EPS Miss as Results Fall Short of Expectations Home BancShares Inc HOMB Q1 2026 Earnings Slight EPS Miss Masked by Strong Underlying Trends APWC Q3 1997 Earnings Missed Estimates Amid Operational Challenges Fastenal Q1 2026 Earnings EPS Falls Short of Estimates Stock Sees Slight Decline Big Tree Cloud Holdings DSY Surges 7 Testing Key Resistance Levels Pfizer PFE Slips Marginally as Stock Tests Key Support Near 246 Pool Corporation POOL Rises 113 as Stock Tests Key Resistance Zone Western Asset Bond Fund WEA Holds Steady Near Support Bond Market Dynamics in Focus Willow Lane Acquisition Corp Unit WLACU Surges 77 Key Levels and What May Come Next Myriad Genetics Slips 23 to 382 as Shares Test Key Support Levels SIGA Technologies SIGA Holds Steady Near Support Amid Low Volatility Carters Inc CRI Continues Slide as Stock Tests Key Support Near MultiYear Lows West Pharmaceutical Services WST Slips 109 as Stock Hovers Above Key Support Nasus Pharma NSRX Edges Higher Approaches Key Resistance Level